All
RSSArticles
-
Internal Medicine Alert - Full November 29, 2010 Issue in PDF
-
Clinical Briefs By Louis Kuritzky, MD
Since the publication of the allhat trial, clinicians have progressively relied upon diuretic-based regimens to manage hypertension (HTN). -
Should Everyone Be on Fish Oils?
Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease. -
Lifetime Follow-up Care after Childhood Cancer
Lifetime surveillance is required after successful treatment of childhood cancers, since up to 75% of survivors develop serious complications and other late effects. -
Dabigatran Etexilate mesylate Capsules (Pradaxa®)
Dabigatran is indicated for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. -
Is It a Coincidence that Death Rhymes with Breath?
Pulmonary function can help predict cardiovascular death risk in individuals in the intermediate-risk group of Framingham Risk Scores. -
Neurology Alert - Full December 2010 Issue in PDF
-
Pharmacology Watch
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions. -
Clinical Briefs in Primary Care Supplement
-
Stroke Alert: A Review of Current Clinical Stroke Literature
How Frequently is Atrial Fibrillation Detected in Patients with Stroke or TIA?